Back to Search
DANIELLE AMOROSO, PHARMD
PHARMD
Pharmacist
NPI: 1720676067Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
28RI03511100(NJ)
Research & Publications (17)
A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer.
PMID 19436300·Br J Cancer·2009
3-trial
Cyclin E correlates with manganese superoxide dismutase expression and predicts survival in early breast cancer patients receiving adjuvant epirubicin-based chemotherapy.
PMID 19385967·Cancer Sci·2009
8-other
An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): data report from Italy.
PMID 18951651·Lung Cancer·2009
3-trial
Fulvestrant treatment is associated with cholesterol plasma level reduction in hormone-receptor-positive metastatic breast cancer patients.
PMID 19556864·Cancer Biol Ther·2009
3-trial
Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel Meeting.
PMID 18083041·Crit Rev Oncol Hematol·2008
8-other
The CAP-CR study: direct medical costs in Italian metastatic colorectal cancer patients on first-line infusional 5-fluorouracil or oral capecitabine.
PMID 18805000·Eur J Cancer·2008
4-observational
A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971.
PMID 18780198·Chronobiol Int·2008
4-observational
First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study.
PMID 18212755·Br J Cancer·2008
3-trial
Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma.
PMID 18087214·Cancer Biol Ther·2007
8-other
Ipsilateral right testicular metastasis from renal cell carcinoma in a responder patient to interleukine-2 treatment.
PMID 17430270·Int J Urol·2007
5-case
(IPr)Pd(acac)Cl: an easily synthesized, efficient, and versatile precatalyst for C-N and C-C bond formation.
PMID 16674054·J Org Chem·2006
8-other
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
PMID 16009955·J Clin Oncol·2005
3-trial
Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study.
PMID 11709564·J Clin Oncol·2001
3-trial
Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial.
PMID 11340373·Oncology·2001
8-other
Management of breast cancer: is there a role for somatostatin and its analogs?
PMID 11275703·Chemotherapy·2001
6-review
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin.
PMID 10895059·Oncology·2000
3-trial
Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial. boccardo@hp380.ist.unige.it.
PMID 10894871·J Clin Oncol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 350 ROUTE 130
EAST WINDSOR, NJ 08520 - Phone
- (201) 726-8438
Quick Facts
- NPI
- 1720676067
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 17
Are you this provider?
Claim Your Profile